IHM

Iguana Healthcare Management Portfolio holdings

AUM $133M
1-Year Est. Return 45.66%
This Quarter Est. Return
1 Year Est. Return
+45.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
-$23.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1 +$5.58M
2 +$2.1M
3 +$1.99M
4
AKCA
Akcea Therapeutics Inc
AKCA
+$1.74M
5
PBYI icon
Puma Biotechnology
PBYI
+$1.73M

Top Sells

1 +$5.61M
2 +$4.53M
3 +$3.42M
4
GKOS icon
Glaukos
GKOS
+$3.3M
5
XLRN
Acceleron Pharma
XLRN
+$2.61M

Sector Composition

1 Healthcare 82.78%
2 Energy 0.61%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESPR icon
1
Esperion Therapeutics
ESPR
$637M
$10.9M 7.08%
165,000
+15,000
CELG
2
DELISTED
Celgene Corp
CELG
$7.83M 5.1%
75,000
IMMU
3
DELISTED
Immunomedics Inc
IMMU
$7.27M 4.74%
450,000
-50,000
BIIB icon
4
Biogen
BIIB
$21B
$7.01M 4.56%
22,000
+2,000
HUM icon
5
Humana
HUM
$33.1B
$5.58M 3.64%
+22,500
AERI
6
DELISTED
Aerie Pharmaceuticals
AERI
$5.08M 3.31%
85,000
-15,000
CI icon
7
Cigna
CI
$79.9B
$5.08M 3.31%
25,000
-1,500
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.92M 3.2%
125,000
ABBV icon
9
AbbVie
ABBV
$406B
$4.84M 3.15%
50,000
-15,000
MRK icon
10
Merck
MRK
$212B
$4.5M 2.93%
83,840
+5,240
ABT icon
11
Abbott
ABT
$224B
$4.28M 2.79%
75,000
-10,000
CLVS
12
DELISTED
Clovis Oncology, Inc.
CLVS
$4.08M 2.66%
60,000
-20,000
ANAB icon
13
AnaptysBio
ANAB
$969M
$4.03M 2.62%
40,000
-10,000
KTWO
14
DELISTED
K2M Group Holdings, Inc
KTWO
$3.15M 2.05%
175,000
-25,000
BMY icon
15
Bristol-Myers Squibb
BMY
$88.8B
$3.06M 2%
50,000
-5,000
SRRA
16
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.98M 1.94%
20,000
+5,000
TSRO
17
DELISTED
TESARO, Inc.
TSRO
$2.9M 1.89%
35,000
+10,000
KPTI icon
18
Karyopharm Therapeutics
KPTI
$94.4M
$2.88M 1.88%
20,000
-6,667
DERM
19
DELISTED
Dermira, Inc.
DERM
$2.78M 1.81%
100,000
-25,000
JUNO
20
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.74M 1.79%
60,000
-15,000
ZBH icon
21
Zimmer Biomet
ZBH
$20.2B
$2.71M 1.77%
23,175
-7,725
SGMO icon
22
Sangamo Therapeutics
SGMO
$193M
$2.46M 1.6%
150,000
-50,000
XENT
23
DELISTED
Intersect ENT, Inc
XENT
$2.43M 1.58%
75,000
-15,000
DHR icon
24
Danaher
DHR
$150B
$2.32M 1.51%
28,200
-11,280
RARE icon
25
Ultragenyx Pharmaceutical
RARE
$3.14B
$2.32M 1.51%
50,000